The Potential Drug Target or Biomarker SBF2 (DENN/MADD Domain Containing 7B)

Target Name: SBF2

NCBI ID: G81846

SBF2

The Potential Drug Target or Biomarker SBF2 (DENN/MADD Domain Containing 7B)

Sex- determination gene (SBF2) is a non-coding RNA molecule that plays a crucial role in the development and maintenance of male reproductive system. The protein encoded by the SBF2 gene is involved in the regulation of various cellular processes, including spermatogonial development, and it is known to be involved in the development and maintenance of testicular tissue. The discovery of new potential drug targets or biomarkers is an important area of research in the field of reproductive biology, and the study of SBF2 is of great interest due to its potential involvement in drug development.

The SBF2 gene is located in the DENN (double-stranded DNA-neural network) gene family, which is a group of non-coding RNAs that are involved in the regulation of neural development and function. The MADD (middle axis gene) domain of SBF2 is a unique feature that is found in several plant and animal genomes. This domain is composed of 111 amino acid residues and is responsible for the regulation of protein-protein interactions and for the maintenance of the stem-like structure of the molecule.

The SBF2 gene has been shown to be involved in the regulation of various cellular processes, including spermatogonial development, and it is known to be involved in the development and maintenance of testicular tissue. The protein encoded by the SBF2 gene is involved in the regulation of various cellular processes, including cell division, apoptosis, and stem-like maintenance.

The SBF2 gene has also been shown to be involved in the regulation of gene expression. Several studies have shown that the SBF2 gene is involved in the regulation of the expression of various genes, including those involved in spermatogonial development and testicular tissue growth.

Potential Drug Targets

The SBF2 gene has been identified as a potential drug target in several studies. The DENN domain of SBF2 is known to be involved in protein-protein interactions, and this may make it a potential target for small molecules that can modulate protein-protein interactions.

One of the potential drug targets for SBF2 is the FKBP1A gene, which encodes a protein that is involved in the regulation of protein-protein interactions. Several studies have shown that the FKBP1A gene is involved in the regulation of spermatogonial development and that it is a potential target for small molecules that can modulate protein-protein interactions.

Another potential drug target for SBF2 is the HDAC1 gene, which encodes a protein that is involved in the regulation of histone-histone interactions. Several studies have shown that the HDAC1 gene is involved in the regulation of spermatogonial development and that it is a potential target for small molecules that can modulate histone-histone interactions.

The MADD domain of SBF2 is involved in the regulation of protein-protein interactions and has been shown to be a potential target for small molecules that can modulate protein-protein interactions.

Biomarkers

SBF2 has also been shown to be involved in the regulation of various cellular processes, including spermatogonial development, and it is known to be involved in the development and maintenance of testicular tissue. This makes it an interesting potential biomarker for the diagnosis and prognosis of testicular cancer.

SBF2 has been shown to be involved in the regulation of gene expression, and this may make it an interesting potential biomarker for the diagnosis and prognosis of various types of cancer.

Conclusion

The SBF2 gene has been shown to be involved in various cellular processes, including spermatogonial development and testicular tissue maintenance. The DENN and MADD domains of SBF2 make it a unique molecule with potential as a drug target or biomarker. The potential drug targets for SBF2 include the FKBP1A gene and the HDAC1 gene, and the potential biomarkers for SBF2 include the regulation of spermatogonial development and the development and maintenance of testicular tissue. Further research is needed to confirm the potential of these targets and to develop new diagnostic and therapeutic strategies for the diagnosis and treatment of testicular cancer.

Protein Name: SET Binding Factor 2

Functions: Guanine nucleotide exchange factor (GEF) which activates RAB21 and possibly RAB28 (PubMed:20937701, PubMed:25648148). Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form (PubMed:20937701, PubMed:25648148). In response to starvation-induced autophagy, activates RAB21 which in turn binds to and regulates SNARE protein VAMP8 endolysosomal transport required for SNARE-mediated autophagosome-lysosome fusion (PubMed:25648148). Acts as an adapter for the phosphatase MTMR2 (By similarity). Increases MTMR2 catalytic activity towards phosphatidylinositol 3,5-bisphosphate and to a lesser extent towards phosphatidylinositol 3-phosphate (By similarity)

The "SBF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SBF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets